Development of allosteric, selective cyclin-dependent kinase 2 (CDK2) inhibitors that are negatively cooperative with cyclin binding and show potential as contraceptive agents
Published in 2022 by
Erik B. Faber,
Jian Tang,
Emily Roberts,
Sornakala Ganeshkumar,
Luxin Sun,
Nan Wang 
,
Damien Rasmussen ,
Abir Majumdar,
Kristen John,
An Yang,
Hira Khalid,
Jon E. Hawkinson,
Nicholas M. Levinson,
Ernst Schönbrunn,
Vargheese Chennathukuzhi
and other authors.
,
Damien Rasmussen ,
Abir Majumdar,
Kristen John,
An Yang,
Hira Khalid,
Jon E. Hawkinson,
Nicholas M. Levinson,
Ernst Schönbrunn,
Vargheese Chennathukuzhi
and other authors.
